Shivani Sachdev, PhD

Grateful for this recognition from @BritPharmSoc

Honoured to begin this new chapter at @CRI_ACTREC @ACTREC_TMC alongside such an incredible group of faculty members 😊

Hearty welcome to @ShivDoesScience Our new faculty addition!!! Shivani is a chemical biologist whose lab focuses on developing antibody-engineering platforms combined with peptide chemistry to probe cell surface protein function in cancer. @biopatrika

Heartiest congratulations to @ShivDoesScience our new faculty for the Pickford Award 2026! Best wishes, Shivani!! @CRI_ACTREC @ACTREC_TMC @biopatrika bps.ac.uk/news/article/b…

Very cool paper! Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity nature.com/articles/s4146…

A preprint annotating the lipoprotein lipase as a cholesterol ester hydrolase is now online. Excellent work by @aakash0308 from our lab @IISERPune biorxiv.org/content/10.648…

@CRI_ACTREC August 2026 PhD: Final list of candidates selected for the @CRI_ACTREC PhD program have been announced on @ACTREC_TMC website under JRF 2026 tab along with the waitlisted candidates. Kindly check the website for more details! @biopatrika

PhD August 2026 intake: 2nd round of in person interviews for PhD kick off from today. Best wishes to all the candidates appearing for the interviews this week. Pls read up on the labs & projects you are interested in! @biopatrika @ACTREC_TMC

ACTREC Life Sciences PhD Intake August 2026 batch List for 2nd round announced In person interview from June 1 to June 5, 2026! Pls plan your travel @biopatrika

Terrific science, engaging discussions, and wonderful camaraderie — the IGIB-ACTREC Conclave beautifully captured the spirit of collaborative science. Conversations with like-minded people are always a pleasure. @IGIBSocial @singhajay518 @foldingINvivo @arpan_parichha @shruthy_suresh @BhallaSherry @Ankesh1406

4/ Leaving with a heavy heart, but excited to step into a new role — stay tuned 🚀

3/ Grateful for an extremely supportive mentor, Ross Cheloha, and for everyone in the lab who made this time so special 🥳

1/ A bittersweet goodbye to the #Cheloha lab at the @NIDDKgov🥹 Five years into this postdoc, and I am walking away with so much more than I ever expected 😇

Evaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactions biorxiv.org/content/10.110…

Degrader Tac-opedia 🔘PROTAC: E3 ligase-targeted proteolysis 🔘DUBTAC: Deubiquitinase stabilization 🔘LYTAC: Lysosome-targeted degradation 🔘Trivalent PROTAC: Multivalent E3 ligase 🔘AUTAC: Autophagy-targeted degradation 🔘RIBOTAC: RNA-targeted degradation 🔘RNA-PROTAC: RNA-binding E3 ligase 🔘BioPROTAC: Antibody/peptide proteolysis 🔘Aptamer-PROTAC: Aptamer proteolysis 🔘GlueTAC: Lysosomal traffic & degradation 🔘Peptide-PROTAC: Peptide-based E3 ligase 🔘NanoTAC: Nanobody-based E3 ligase H/T: Donggeon Kim on the HR app!